Stay updated with breaking news from Gunnar Tepe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shockwave IVL Maintains Superiority to Angioplasty in Calcified Peripheral Disease at Two Years - read this article along with other careers information, tips and advice on BioSpace
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
May 19, 2022—Shockwave Medical, Inc. announced long-term data from the DISRUPT PAD III trial evaluating the company’s intravascular lithot
/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...
/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...